An inhibitor of the protein kinases TBK1 and IKK- improves obesity-related metabolic dysfunctions in mice
According to the FDA, similar semaglutide injections for weight loss may be able to help 70% of adult Americans that struggle with obesity or being overweight
as well as neuro-cognitive complications such as brain fog, sleep disorders and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), which are persistent among PASC 656,657
Wu L, Zhou M, Li T, Dong N, Yi L, Zhang Q, et al
Note too that lipotropic injections without prescription medications arent regulated by the FDA
doi: 10.1016/j.phrs.2019.104321 16